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Notch signaling has a fundamental role in stem cell maintenance and in cell fate choice in the intestine
of different species. Canonically, Notch signaling represses the expression of transcription factors of the
achaete-scute like (ASCL) or atonal related protein (ARP) families. Identifying the ARP/ASCL genes
expressed in the gastrointestinal tract is essential to build the regulatory cascade controlling the
differentiation of gastrointestinal progenitors into the different intestinal cell types. The expression of
the ARP/ASCL factors was analyzed in zebraﬁsh to identify, among all the ARP/ASCL factors found in the
zebraﬁsh genome, those expressed in the gastrointestinal tract. ascl1a was found to be the earliest
factor detected in the intestine. Loss-of-function analyses using the pia/ascl1a mutant, revealed that
ascl1a is crucial for the differentiation of all secretory cells. Furthermore, we identify a battery of
transcription factors expressed during secretory cell differentiation and downstream of ascl1a. Finally,
we show that the repression of secretory cell fate by Notch signaling is mediated by the inhibition of
ascl1a expression. In conclusion, this work identiﬁes Ascl1a as a key regulator of the secretory cell
lineage in the zebraﬁsh intestine, playing the same role as Atoh1 in the mouse intestine. This highlights
the diversity in the ARP/ASCL family members acting as cell fate determinants downstream from Notch
signaling.
& 2013 Elsevier Inc. All rights reserved.Introduction
The gastrointestinal tract contains the largest population of
hormone-producing cells in the body. Enteroendocrine cells are
scattered throughout the digestive epithelium, embedded in a
majority of non-endocrine cells, including the absorptive enter-
ocytes and the mucus-secreting goblet cells. They secrete over
10 different peptide hormones, regulating important physiologi-
cal functions such as glycemia, exocrine pancreatic secretion and
food intake (reviewed by (Murphy and Bloom, 2006)). Thus,
understanding enteroendocrine cell differentiation is essential
for identifying future targets for common disease such as diabetes
and obesity (reviewed by (Li et al., 2011)).
The earliest cell fate decisions for the speciﬁcation of the
different intestinal cell lineages appear to be regulated by the
Notch signaling pathway (reviewed by (Schonhoff et al., 2004)).ll rights reserved.
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fertilizationIn mouse, activation of Notch signaling in the intestine inhibits
cell differentiation of all secretory cells, i.e. goblet, Paneth and
enteroendocrine cells, resulting in a large increase in the number
of progenitor cells (Fre et al., 2005; Stanger et al., 2005). Inversely,
inactivation of Notch signaling at adult stage leads to a decrease
in the number of progenitors due to excessive differentiation of
goblet cells, that populate almost entirely the villi, at the expense
of the absorptive enterocytes (Jensen et al., 2000; Pellegrinet
et al., 2011; Riccio et al., 2008; van Es et al., 2005). The effect of
Notch inactivation on enteroendocrine cells or Paneth cells
differentiation is still unclear. Disruption of Notch pathway in
Hes1 knockout embryos show also increased numbers of enter-
oendocrine and Paneth cells (Jensen et al., 2000) while somewhat
different results were seen in adult mice treated with g secretase
inhibitors (van Es et al., 2005) or in mice where various compo-
nents of the Notch signaling pathway were conditionally deleted
at adult stages (RBP-jk, Delta1/Delta4, Notch1/Notch2)(Pellegri-
net et al., 2011; Riccio et al., 2008; van Es et al., 2005). Disruption
of Notch in this context resulted in massive expansion of the
goblet cell lineage with little or no effect on the number of
enteroendocrine cells and Paneth cells. Such discrepancy could
result from a Notch-independent expression of Hes-1 as reported
in different systems (Curry et al., 2006; Ingram et al., 2008;
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levels of remaining Notch signaling could also explain such
discrepancy as the single Delta1 KO has been reported to display
an increase of all three types of secretory cells (Stamataki et al.,
2011) while in the double KO Delta1/Delta4, only goblet cells are
increased (Pellegrinet et al., 2011). Finally, different timings of
Notch inactivation could also inﬂuence the outcome, therefore it
is important to determine the time windows when Notch signal-
ing affects the formation of the different intestinal cell types.
Notch proteins are transmembrane receptors that interact with
DSL (Delta Serrate Lag) cell surface ligands from neighboring cells
(reviewed by (Schonhoff et al., 2004)). Ligand binding activates a
series of proteolytic clivages of Notch, releasing from the membrane
the Notch intracellular domain that will translocate to the nucleus
and activate members of the Hairy Enhancer of Split family. These
repressors will then inhibit the expression of cell fate determinants
that are usually members of the Achaete scute-like (ASCL) family or
of the atonal related proteins (ARP) family, this latter family being
further subdivided into Atonal, Neurogenin and NeuroD subfamilies.
In mouse, several members of these families have been shown to be
key regulators of gastrointestinal cell differentiation and, depending
of the location in the digestive tract, different sets of cell fate
determinants are involved (Jenny et al., 2002; Mellitzer et al.,
2010; Shroyer et al., 2007; Yang et al., 2001). For example, ASCL1
(Mash1) is absolutely required for the differentiation of all endocrine
cells in the stomach (Kokubu et al., 2008) but is not expressed in the
intestine (Jensen et al., 2000; Kokubu et al., 2008) while ATOH1
(Math1) is absolutely required for enteroendocrine and goblet cell
differentiation in the intestine (Shroyer et al., 2007; Yang et al.,
2001) but is not expressed in the stomach (Yang et al., 2001). Ngn3
is the cell fate determinant of the endocrine lineage in the intestine
(Jenny et al., 2002; Mellitzer et al., 2010) but is important for only a
subsets of enteroendocrine cells in the stomach. Many unanswered
questions still remain regarding notably how the different enter-
oendocrine subtypes are speciﬁed and what are the factors or
signaling events that control the choice between goblet and enter-
oendocrine cell fate. Identifying all transcription factors involved in
these processes and understanding the spatial and temporal expres-
sion of these factors during intestinal differentiation is required in
order to build the regulatory cascade controlling the differentiation
of gastrointestinal progenitors into secretory cells.
The analysis of Notch function in the same organ of different
species is also valuable as it allows exploiting the speciﬁc
advantages of each model system to highlight both conserved
and divergent functions across species (Fre et al., 2011). One of
the advantages of the zebraﬁsh model is the possibility to
visualize the expression proﬁle of a particular factor at once in
the whole animal by whole-mount in situ hybridization (WISH)
and to analyze easily in the whole digestive system the pheno-
typic defects caused by its loss-of-function. The functional orga-
nization of the zebraﬁsh digestive system is similar to mammals;
however, its morphology is simpler. The zebraﬁsh gastrointestinal
tract does not have a discrete stomach but the anterior part of the
gut tube is enlarged to form a food-storage compartment known
as the intestinal bulb. This bulb and the adjacent mid-intestine
are involved in lipid absorption. Most of the posterior intestine is
an absorption zone for proteins while the caudal end is specia-
lized in ion transportation and water absorption, like the colon of
mammals. There are no ‘‘crypts of Lieberkuhn’’ in the zebraﬁsh
intestinal epithelium but intervillus pockets which are, as the
crypts, the site of cell proliferation required for the intestinal
turnover but which do not contain Paneth cells. The villi contain
three types of differentiated cells, namely, enterocytes, goblet and
enteroendocrine cells (Crosnier et al., 2005; Wallace et al., 2005).
Like in mammals, Notch signaling plays an essential role in the
control of intestinal homeostasis in zebraﬁsh. Indeed, the brombones mutants, that exhibit increased Notch signaling, display
hyperproliferation of the adult intestinal epithelium and compro-
mised secretory goblet cell differentiation; however the consequence
on enteroendocrine cell differentiation was not investigated (Yang
et al., 2009). Inversely, in the mind bomb (mib) mutants where the
Notch signaling pathway is inactivated, almost all the cells in the
3-day gut epithelium adopt a secretory fate as revealed by the
monoclonal antibody 2F11, that recognizes both enteroendocrine
and goblet cells (Crosnier et al., 2005). A role of Notch on enter-
oendocrine cell differentiation is suggested by an increase of
Glucagon-like peptide (Glp) expressing cells in the mib mutant
(Zecchin et al., 2007). The question whether both goblet and
enteroendocrine cell fates are favored in the mib mutant remains
unanswered.
In this study, we analyzed the effect of Notch inactivation on
the different secretory cell types of the zebraﬁsh intestine and
determined the critical time window of Notch action. Moreover,
we identiﬁed ascl1a as the ﬁrst ARP/ASCL factor expressed in the
gastrointestinal tract and found that it acts directly downstream
of Notch signaling to promote secretory cell fate.Materials and methods
Zebraﬁsh maintenance and mutant lines
Zebraﬁsh (Danio rerio) were raised and cared for according to
standard protocols (Westerﬁeld, 1995). Wild-type embryos from
the AB strain were used and staged according to Kimmel (Kimmel
et al., 1995). The pia mutant (piat25215 mutant allele of ascl1a) was
provided by M. Hammerschmidt and genotyped as described
(Pogoda et al., 2006). Homozygous mind bomb mutants were
obtained by mating heterozygous ﬁsh for the mibta52b allele
(Haddon et al., 1998).
Riboprobes, whole-mount in situ hybridization (WISH)
Antisense riboprobes were made by transcribing linearized cDNA
clones with SP6, T7, or T3 polymerase using digoxigenin or DNP
labeling mix (Roche) according to manufacturer’s instructions. They
were subsequently puriﬁed on NucAway spin columns (Ambion) and
ethanol-precipitated. The zebraﬁsh fabp2 (Mayer and Fishman, 2003)
agr2 (Shih et al., 2007), ascl1a (Allende and Weinberg, 1994), ascl1b
(Allende and Weinberg, 1994), sox4b (Mavropoulos et al., 2005), isl1
(Korzh et al., 1993), neurod1 (Korzh et al., 1998), pax6b (Krauss et al.,
1991), rfx6 (Soyer et al., 2010), ngn3 (Wang et al., 2001), nkx2.2 (Barth
and Wilson, 1995), somatostatin2 (Devos et al., 2002), ghrelin (NCBI:
AL918922), pyyb (GenBank: AL909489) and gcga (Argenton et al.,
1999) probes have been described elsewhere. Single whole-mount
and double ﬂuorescent in situ hybridizations were carried out as
described (Mavropoulos et al., 2005).
Immunochemistry
Whole-mount immunohistochemistry were performed as pre-
viously described (Dong et al., 2007). We used the monoclonal
mouse 2F11 primary antibody (Crosnier et al., 2005) (1:1000,
abcam ab71286), the mouse monoclonal mouse 4E8 primary
antibody (1:150, abcam ab73643) (Crosnier et al., 2005), and
ﬂuorescently conjugated Alexa-488 antibody for detection (Mole-
cular Probes). Goblet cell mucin was detected with rhodamine
conjugated wheat germ agglutinin (1:100 dilution) (Vector
Laboratories). The nuclei were stained by TO-PRO-3 iodide (642/
661 nm, Invitrogen) or by Draq7
TM
(Biostatus limited) and
embryos were mounted in ProLong Gold Antifade reagent
(Invitrogen).
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Microscope pictures were performed with an Olympus DP70
photocamera ﬁxed on a BX60 Olympus microscope. Confocal
imaging was performed using a Leica TCS SP2 inverted confocal
laser microscope (Leica Microsystems, Germany). Digitized
images were acquired using a 63X (NA 1.2) Plan-Apo water-
immersion objective at 10241024 pixel resolution. For multi-
color imaging, FITC was visualized by using an excitation wave-
length of 488 nm and the emission light was dispersed and
recorded at 500–535 nm. Cy3 was detected by using an excitation
wavelength of 543 nm and the ﬂuorescence emission was dis-
persed and recorded at 555–620 nm. TO-PRO-3 iodide and
Draq7
TM
were detected by using an excitation wavelength of
633 nm and the ﬂuorescence emission was dispersed and
recorded at 650–750 nm. The acquisition was set up to avoid
any cross-talk of the two ﬂuorescence emissions. Series of optical
sections were carried out to analyze the spatial distribution of
ﬂuorescence, and for each embryo, they were recorded with a
Z-step ranging between 1 and 2 mm. Image processing, including
background subtraction, was performed with Leica software
(version 2.5). Captured images were exported as TIFF and further
processed using Adobe Photoshop and Illustrator CS2 for ﬁgure
mounting.
Morpholino design and injection
The sox4b morpholino was designed by Gene Tools and is
complementary to the 50UTR (50-GACTCAGTCTGATTGCACA-
CAGTCC-30). A standard control MO, having the sequence:
50-CCTCTTACCTCAGTTACAATTTATA-30 has been also designed by
Gene Tools in a way that it should have no target and no signiﬁcant
biological activity. They were dissolved at a concentration of 3 mg/
ml in 1x Danieau buffer containing 0.5% of rhodamine dextran (to
follow the microinjection process) and microinjected at the 1–2
cells stage at a dose of 6 ng. Injected embryos were then grown in
the presence of 0.003% 1-phenyl-2-thiourea until the desired stage,Fig. 1. ascl1a is expressed in the precursor cells of the gastrointestinal tract. Ventral vie
ﬂuorescent WISH (E and F). (A) General view of ascl1a expression domain at 55 hpf. (B)
(dotted lines) and in enteric neurones that lined these cells (arrows). (C) At 58 hpf, this
cells begins to decrease along the gastrointestinal tract. (E and F) Confocal sections show
gcga probe (E) neither in the mature goblet cells labeled by agr2 (F). Scale bars: 50 mMﬁxed overnight in 4% PFA and stored in 100% methanol before
analysis.
Drug inhibition of Notch-signaling in larvae
N-[N-(3,5-Diﬂuorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl
ester (DAPT, D 5942, Sigma), a presenilin g-secretase inhibitor was
used to block Notch-signaling. A 100 stock solution of 10 mM
DAPT in DMSO was made and stored at 20 1C until use. Embryos
were dechorionated and incubated in 100 mM of DAPT in E3
(Geling et al., 2002). Embryos incubated in 1% DMSO in E3 were
used as control.Results
ascl1a is expressed in the precursor cells of the gastrointestinal tract
As cell-fate commitment controlled by Notch signaling is
canonically carried out via ARP/ASCL factors, we searched for
ARP/ASCL factors that would act as cell fate determinants in the
gastrointestinal tract. Among the 14 ARP/ASCL factors found in the
zebraﬁsh genome (Wang et al., 2009), we found that ascl1awas the
ﬁrst to be expressed in the gastrointestinal tract. In addition to its
previously reported expression in the nervous system and in the
adenohypophysis (Allende and Weinberg, 1994; Pogoda et al.,
2006), we found a strong expression of ascl1a in the intestine
(Fig. 1 et Fig. S1) while its paralog ascl1b was not detectable in this
tissue (data not shown). The expression of ascl1a in the primitive
gut begins at 36 hpf in few scattered cells and become easily
detectable at 40 hpf (Fig. 1B). ascl1a shows a punctuate distribution
in the intestinal epithelium (see Supplemental Fig. S1), which
consists at that stage of a thin layer of cuboidal cells (Ng et al.,
2005). As previously reported (Lucas et al., 2006), the enteric
neuron progenitors found in the mesenchyme surrounding the
intestinal epithelium also express ascl1a (arrows in Fig. 1B). At 58
hpf, the anterior region of the intestinal epithelium has expandedws with anterior on the left of embryos analyzed by visible WISH (A–D) or double
At 40 hpf, ascl1a is expressed in cuboı¨dal cells scattered in the primitive intestine
scattered expression is still intense. (D) At 72 hpf, the number of ascl1a expressing
ing that ascl1a is not expressed in the mature enteroendocrine cells labeled by the
.
Fig. 2. Absence of the secretory lineage in the ascl1a/piamutant. Upper part: Scheme depicting the organization of the zebraﬁsh gastrointestinal tract. Lower part: Confocal
projections of ventral views of embryos with the anterior to the left analyzed by ﬂuorescent WISH (A–F, K and L), by labeling with a rhodamine dextran-conjugated wheat
germ agglutinin (WGA) (G and H) or by 2F11 immunohistochemistry (I and J). (A–F) The pia mutants lack the enteroendocrine cells expressing pyyb (B) or gcga (D) as well
as the goblet cells expressing arg2 (F). (G–H) Goblet cell mucin, revealed by rhodamine-dextran labeled WGA, is absent in the pia mutant. (I and J) Immunohistochemistry
with 2F11 antibody conﬁrms that the whole secretory lineage is missing in the gastrointestinal tract (dotted lines) of the piamutant. (K and L) The absorptive cells, labeled
with the fabp2 probe, are still present in the pia mutant. Scale bars: 50 mM.
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Fig. 3. Ascl1a is a key regulator of the secretory cell differentiation cascade. (A) Diagram illustrating the expression window of the transcription factors and hormones in
the gastrointestinal tract. The interval of time where the gene has been shown to be expressed is represented by a solid line whereas the gene expression was not analyzed
during the periods outlined by dotted lines. The references for these data are as follows: a (this paper), b (Ng et al., 2005), c (Zecchin et al., 2007), d (Delporte et al., 2008),
e (Wallace et al., 2005). (B–L) Ventral views with anterior to the left of embryos analyzed by ﬂuorescent WISH (B–J) or visible WISH (K and L) (B–D) Confocal sections
showing that ascl1a expression co-localize perfectly with sox4b expression in scattered cells of the primitive intestine (dotted line) at 48 hpf. (E–J) Confocal projections
showing that all the gastrointestinal cells expressing sox4b, isl1 or rfx6 are absent in the pia mutant whereas the pancreatic expression of these factors is not affected
(K and L) ascl1a expression is not affected upon Sox4b knock-down. P, pancreas; Arrow, enteric neurone. Scale bars: 50 mM.
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scattered throughout the primitive gut (Fig. 1C). The intestinal
expression of ascl1a begins to decrease at 72 hpf (Fig. 1D), time
where the ﬁrst hormones begin to be expressed by the enteroen-
docrine cells (i.e pyyb, gcga) (Ng et al., 2005). Finally, ascl1a
expression disappears shortly after 84 hpf.
Double ﬂuorescent in situ hybridization using ascl1a and gcga
(processed into Glp in intestinal cells) (Fig. 1E) or peptide tyrosine
tyrosine b (pyyb) probes (data not shown) did not reveal any co-
localisation between ascl1a and these two hormones. Moreover, we
did not observe any co-expression of ascl1a with agr2, a marker of
mature goblet cells, coding for a protein disulﬁde isomerase
essential for Mucin2 maturation (Shih et al., 2007) (Fig. 1F). The
absence of ascl1a expression in mature secretory cells and its
precocious expression in the intestinal epithelium suggest that
ascl1a could label precursor cells in the gastrointestinal tract.
Absence of the secretory lineage in the intestine of ascl1a/pia mutants
To determine the role of Ascl1a in intestine development, we
analyzed the phenotype of the pituitary absent (pia) mutant,
carrying a null mutation within the ascl1a gene (Pogoda et al.,
2006). This point mutation is a nucleotide substitution changing
the tyrosine codon at position 70 to a premature stop codon
resulting in a truncated Ascl1a protein that lacks all the
C-terminal amino acid residues including the entire bHLH domain.
In wild-type embryos, expression of pyyb was mainly detected
in enteroendocrine cells of the intestinal bulb while gcga expression
is essentially found in enteroendocrine cells of the mid and poster-
ior gut (Fig. 2A and C and see upper scheme). In the pia mutant,Fig. 4. All the cells of the gut epithelium adopt either a goblet or enteroendocrine fate in
by immunohistochemistry with 2F11 together with the binding of ﬂuorescent WGA (A an
The gut of 5-daymibmutants is nearly completely covered by secretory cells, either enter
midgut, or goblet cells (2F11þ/WGAþ). C and D: The presence of goblet cells in the gut
headed arrows indicate the length of the gut. E and F: 84 hpf mib larvae display a nearlneither pyyb nor gcga expression was detectable in the gastro-
intestinal tract (Fig. 2B, D). We next investigated goblet cells
distribution in the gut epithelium by WISH using an agr2 probe
or by the binding of a ﬂuorescently labeled wheat germ agglutinin
(WGA) that interacts with the N-acetylglucosamine of the mucus
(Wallace et al., 2005). Goblet cells were easily detected in the
middle and posterior segments of the intestine of wild-type larvae
at 84 hpf and 120 hpf, (Fig. 2E and G). In contrast, no goblet cells
were found in the pia larvae (Fig. 2F and H). The absence of goblet
cells and of pyyb- or gcga-enteroendocrine cells indicate that the
secretory lineage is severely affected in the pia mutants. To
determine whether the whole secretory lineage is perturbed, we
performed an immunolabelling using the antibody 2F11 that
recognizes both goblet and enteroendocrine cells (Crosnier et al.,
2005) (Fig. 2I). No 2F11 positive cells were present in the gastro-
intestinal tract of the pia mutant (Fig. 2J). In contrast, the
absorptive lineage seems unaffected as enterocytes, labeled by
fabp2 (fatty acid binding protein 2, intestinal) probes, were detected
in the piamutants like in the wild-type siblings (Fig. 2K and L). This
conclusion was further supported by immunohistochemistry using
the 4E8 antibody, described to stain the brush border of the
absorptive cells (Crosnier et al., 2005). As shown on supplemental
Fig. S2C and D, the brush border of the enterocytes seems to be
correctly formed in the pia mutant at 5 dpf. Furthermore, the
general morphology of the digestive tract does not appear dis-
turbed as revealed by the TO-PRO-3 iodide labeling of the cell
nuclei (Fig. S2A and B).
All these data indicate that, during zebraﬁsh embryogenesis,
Ascl1a is essential for the formation of all intestinal secretory cells
but not for the generation of the absorptive cells.themibmutant. Ventral views with anterior to the left of wt ormib embryos labeled
d B) or byWISH using the agr2 probe (C and D) or the fabp2 probe (E and F). A and B:
oendocrine cells (2F11þ/WGA), found preferentially in the intestinal bulb and the
of mib mutant at 4 dpf was conﬁrmed by WISH using the agr2 probe. The double-
y complete loss of fabp2-labeled enterocytes. Scale bars: 50 mM.
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To date, there are only a few transcription factors known to be
expressed in the secretory lineage in the zebraﬁsh intestine.
To our knowledge, only pax6b, ngn3, nkx2.2 and neurod1 were
reported as expressed in scattered cells of the gut (Delporte et al.,
2008; Ng et al., 2005; Zecchin et al., 2007). These factors are
known to be important for enteroendocrine cell differentiation in
mice (Desai et al., 2008; Hill et al., 1999; Jenny et al., 2002;
Larsson et al., 1998; Lee et al., 2002; Mutoh et al., 1997, 1998;
Naya et al., 1997; Schwitzgebel et al., 2000). These four factors areFig. 5. Notch signaling acts between 25 hfp and 40 hpf to repress enteroendocrine ce
embryos analyzed by visible (A, D and E) or ﬂuorescent (C) WISH. (A) ascl1a ex
(B) Quantiﬁcation of the total number of enteroendocrine cells present in the whole i
cells have been directly counted under the microscope. Fold increase represents the me
DMSO treated embryos. Asterisks indicate that the difference between the cell number
test. ***Po0.0001; **Po0.001; *Po0.05. (C) Confocal projections of 75 hpf embryos lab
DMSO from 30 hpf to 75 hpf. P, pancreas (D and E) ascl1a expression at 55 hpf is increas
in embryos treated from 40 to 55 hpf (G).also involved in pancreatic endocrine cell differentiation, suggest-
ing that a similar regulatory cascade controls the differentiation
of endocrine cells in both the pancreas and the intestine. This
observation led us to analyze the expression of other pancreatic
transcription factors in the gastrointestinal tract. Three additional
transcription factors, namely sox4b, isl1 and rfx6 were detected in
scattered cells of the intestine (Fig. 3E, G and I). Expression of
these seven pancreatic transcription factors was analyzed at
different time points during gastrointestinal differentiation in
order to deﬁne the onset of their expression and their distribution
in the gut (see recapitulative scheme in Fig. 3A). We found thatll differentiation and ascl1a expression. Ventral views with anterior to the left of
pression is strongly increased in the primitive gut of 45 hpf mib embryos.
ntestine and labeled with a mixture of pyyb, gcga, sst and ghrelin. These positive
an (þS.EM.) of the enteroendocrine cells number in DAPT treated embryos versus
in control and embryos treated with DAPT is statistically signiﬁcant by Student’s t-
eled with a mixture of pyyb, gcga, sst and ghrelin probes and treated with DAPT or
ed in the primitive gut of embryos treated with DAPT from 25 to 55 hpf (E) but not
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marker of endocrine precursors in the pancreas, begins to be
expressed in few cells of the gut at 36 hpf and is easily detectable
at 40 hpf like ascl1a. Furthermore, sox4b was found to co-localize
with ascl1a at all examined stages (40 hpf, 48 hpf, 58 hpf)
(Fig. 3B–D and data not shown). Expression of neurod1, nkx2.2,
rfx6, pax6b and isl1 was detected between 50 and 65 hpf (Fig. 3A).
ngn3 expression was not detected before 72 hpf and only in few
cells of the gastrointestinal tract (supplemental Fig. S3, G). Its
onset of expression occurs approximately at the same time as the
hormones pyyb, ghrelin, gcga and somatostatin. Finally, agr2, a
marker of mature goblet cells (Shih et al., 2007) is easily detected
from 84 hpf onwards.
None of these seven transcription factors were detected in
the gastrointestinal tract of the pia mutants (Fig. 3F, H, J and S3
A–H). In contrast, the expression of all these factors was not
perturbed in the pancreas indicating that Ascl1a controls endo-
crine cell differentiation in the intestine but not in the pancreas.
The absence of pancreatic effect is not surprising as we found
that ascl1a is barely detectable in a small number of pancreatic
cells (data not shown). To further analyze the genetic hierarchy
between Ascl1a and Sox4b, we analyzed ascl1a expression after
Sox4b inactivation. The injection of the antisense morpholino
Mo1sox4b, targeting the 50UTR of sox4b mRNA and known to
efﬁciently block sox4b translation, does not affect ascl1a expres-
sion at 55 hpf (Fig. 3K and L) while inhibiting the pancreatic
expression of glucagon as previously reported (Mavropoulos
et al., 2005).
All these data indicate that Ascl1a acts at the beginning of the
intestinal secretory cell differentiation cascade and is a key regulator
playing a pivotal role in the speciﬁcation of the secretory cell lineage.Fig. 6. Ascl1a is required for the induction of secretory cell fate upon inhibition of th
double ﬂuorescent WISH using a agr2 probe (green) and with a mixture of gcga, sst and
treated with DAPT from 25 to 96 hpf show an increased number of enteroendo
(B and D) pia embryos treated with DMSO or DAPT from 25 to 96 hpf are devoid or seAscl1a acts downstream of Notch signaling to promote
secretory cell fate
In order to establish the genetic relationship between Notch
signaling and Ascl1a, we analyzed the expression of ascl1a in the
mib mutant where the Notch signaling pathway is inactivated (Itoh
et al., 2003). mib embryos display a strong increase in the number of
ascl1a-expressing cells with almost all intestinal cells expressing that
gene. In contrast, the wild-type embryos show a ‘‘salt and pepper’’
distribution, as classically found for genes repressed by the Notch
lateral inhibition process (Fig. 5A).
Previous analyses of mib mutant larvae has revealed that
almost all the cells in the 3-day gut epithelium adopt a secretory
fate (Crosnier et al., 2005); however, it was not determined
whether both goblet and enteroendocrine fate is adopted in these
mutants. Thus, we performed an immunohistochemistry using
the monoclonal antibody 2F11, that recognizes both enteroendo-
crine and goblet cells, combined with the binding of ﬂuorescent
WGA labeling the goblet cells. As shown on Fig. 4F, we found in
mib larvae a nearly complete loss of fabp2-labeled enterocytes.
These data conﬁrm previous reports showing a dramatic reduc-
tion of absorptive cells labeled with the brush border antibody
4E8 (Crosnier et al., 2005) or with the oligopeptide transporter
PepT1 probe (Zecchin et al., 2007). The gut of mib mutants, which
is reduced in size, is nearly completely covered by secretory cells
(Fig. 4B), either enteroendocrine cells (2F11þ/WGA), found
preferentially in the bulb and the midgut, or goblet cells
(2F11þ/WGAþ). The presence of goblet cells in the gut of mib
mutant was conﬁrmed by WISH using the agr2 probe (Fig. 4D).
To deﬁne the time window when Notch signaling is required
for repressing the secretory fate, we treated wild-type embryose Notch pathway. Ventral views with anterior to the left of embryos analyzed by
ghrelin probes (red). All pictures are confocal projections. (A and C) WT embryos
crine and goblet cells (fold increase of 2.270.5 and 1.570.4, respectively).
cretory cells in the gastrointestinal tract. P, pancreas. Scale bars: 50 mM.
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(Geling et al., 2002). The number of enteroendocrine cells was
determined at 75 hpf by WHISH using a cocktail of probes for four
hormones (pyyb, gcga, ghrelin and somatostatin). Treatments
starting at 25 or 30 hpf (25–75 hpf or 30–75 hpf) led to a
signiﬁcant increase in the number of enteroendocrine cells
(Fig. 5B, C) while treatment initiated at 40 hpf or 45 hpf had no
effect on the number of enteroendocrine cells (Fig. 5B). When the
treatment began at 35 hpf, a moderate increase in the number of
endocrine cells was observed (Fig. 5B). All these data indicate that
Notch signaling represses enteroendocrine cell fate in a limited
time window that occurs between 25 and 40 hpf during embryo-
nic development.
To determine whether the repression of the enteroendocrine cell
fate mediated by Notch signaling occurs through the regulation of
ascl1a expression, we ﬁrst compared ascl1a expression in embryos
treated with DAPT from 25 hpf to 55 hpf versus embryos treated from
40 to 55 hpf (Fig. 5D–E). Consistent with the moment when Notch is
required, the number of ascl1a-expressing cells was increased only
with the ﬁrst treatment suggesting that the activity of Notch signaling
could be mediated through the regulation of ascl1a expression. To
further support this assertion, we investigated the consequence of
ascl1a loss-of-function combined with Notch inhibition by treating
the piamutants with DAPT from 25 hpf to 96 hpf. Inhibition of Notch
signaling in wild-type embryos results in an excessive differentiation
of enteroendocrine cells and goblet cells (Fig. 6A–A0, C–C0). In contrast,
no secretory cells were observed in the pia mutants with or without
Notch signaling inhibition (Fig. 6B–B0, D–D0). This demonstrates that
the induction of the secretory cell fate upon disruption of Notch
signaling requires Ascl1a.
Taken together, all these data indicate that Notch signaling
represses secretory cell fate by inhibiting ascl1a expression.Discussion
Our ﬁndings provide new insights into the role of Notch in
controlling differentiation of intestinal epithelial lineages during
zebraﬁsh embryogenesis. We found that Notch signaling represses
both goblet and enteroendocrine cell differentiation via the repression
of ascl1a expression. ascl1a, expressed in the intestinal precursors at
early stages, is indispensable for the speciﬁcation of the secretory cell
lineage. It acts upstream of a battery of transcription factors, thereby
placing it at the top of the secretory cell differentiation cascade.ascl1a is the ﬁrst ARP/ASCL gene expressed in the gastrointestinal
tract
Among the 14 ARP/ASCL genes found in the zebraﬁsh genome
(Wang et al., 2009), ascl1a is the ﬁrst to be expressed in the
gastrointestinal tract. ascl1a is expressed in scattered cells of the
epithelium of the gastrointestinal tract, long before the apparition
of the ﬁrst mature intestinal cells, and never co-localizes with
markers of mature secretory cells. The disseminated distribution
of ascl1a is a sign of lateral inhibition, which allows the genera-
tion of secretory cells scattered within the intestinal epithelium.
This ‘‘salt and pepper’’ distribution of ascl1a positive cells and the
loss of all secretory cells in ascl1a mutants suggests that ascl1a is
expressed in all precursors of the secretory cell lineage but not in
the enterocytes precursors. Furthermore, sox4b, which is a marker
of endocrine cell precursors in the pancreas, is co-expressed with
ascl1a in the intestine at all tested stages. This suggests that both
sox4b and ascl1a are markers of secretory lineage precursors.
However, cell lineage experiments are required to deﬁnitively
prove this hypothesis.Many pancreatic transcription factors are also expressed
in the gastrointestinal tract
There is a striking similarity in the transcription factors expressed
in the endocrine cells of the pancreas and of the gastrointestinal tract.
Indeed, several transcription factors expressed in the enteroendocrine
cells in mouse and zebraﬁsh, such as Pax6 (Delporte et al., 2008; Hill
et al., 1999; Larsson et al., 1998), Ngn3 (Jenny et al., 2002; Lee et al.,
2002; Schwitzgebel et al., 2000; Zecchin et al., 2007), Neurod1
(Mutoh et al., 1997, 1998; Zecchin et al., 2007), Nkx2.2 (Desai et al.,
2008; Ng et al., 2005), Isl1 (Larsson et al., 1995) (this study), are also
essential for pancreatic endocrine differentiation (Kinkel and Prince,
2009; Rojas et al., 2010). Moreover, we found that two other
pancreatic factors, sox4b and rfx6, are also expressed in the zebraﬁsh
intestine. The detailed analysis of the expression proﬁle of these
seven factors allowed us to establish the order of their apparition,
giving us a hint about the regulatory cascade driving enteroendocrine
cell differentiation in zebraﬁsh. The ﬁrst transcription factors that
appear in the gastrointestinal tract are ascl1a and sox4b which are
detectable from 36 hpf onwards. Then, the factors neurod1, nkx2.2,
rfx6, pax6b and isl1 appear between 50 and 65 hpf and ﬁnally ngn3
whose expression is detectable only from 72 hpf, when the ﬁrst
enteroendocrine cells are already differentiated (see diagram Fig. 3A).
The relatively late onset of ngn3 expression in the zebraﬁsh gastro-
intestinal epithelium is not in favor of a role of this factor as cell fate
determinant of the enteroendocrine cell lineage. In mice intestine,
Ngn3 is expressed long before the ﬁrst enteroendocrine cells are
differentiated and is required for the differentiation of all these cells
(Jenny et al., 2002). In contrast, in the stomach, Ngn3 expression is
only involved in the differentiation of a subset of enteroendocrine
cells (Jenny et al., 2002; Lee et al., 2002). As ngn3 expression appears
at late stages in zebraﬁsh, it is possible that it affects only the
subpopulation of enteroendocrine cells appearing at later stages, such
as GIP, GRP, NPY or PYY expressing cells (Musson et al.,
2009)(unpublished data).
Notch signaling represses the secretory cell fate by inhibiting
ascl1a expression
In zebraﬁsh as in mouse, secretory cell differentiation is controlled
by Notch signaling. In mouse, Notch activation inhibits cell differ-
entiation of all intestinal secretory cells (Fre et al., 2005; Stanger et al.,
2005) while Notch inhibition leads to an excessive differentiation of
goblet cells (Jensen et al., 2000; Riccio et al., 2008; van Es et al., 2005).
The actual role of Notch pathway in the differentiation of the murine
enteroendocrine and Paneth cells is still unclear. In zebraﬁsh, Notch
signaling activation using the brom bones mutant shows a defect in
goblet cell speciﬁcation in adult but the effect on enteroendocrine
cells was not investigated (Yang et al., 2009). Notch signaling
inactivation using the mib mutants revealed that almost all the cells
in the gut epithelium adopt a secretory fate, either goblet or
enteroendocrine fate (this study, (Crosnier et al., 2005; Zecchin
et al., 2007)). As a consequence of the loss of absorptive cells, ascl1a
staining is found in nearly all the cells of the gut of the mib mutant.
DAPT treated embryos show also an increase of ascl1a expressing
cells but the cells remain scattered in the gut probably due to the
presence of enterocytes in the DAPT-treated embryos. Such differ-
ences between mib mutant and DAPT treated embryos can be
explained by either an incomplete blocking of Notch activity by the
DAPT treatment or by the different timing of Notch inactivation.
Indeed, DAPT treatment was performed only from 25 hpf onwards
while the early inactivation of Notch signaling in the mib mutant can
affect additional processes like endoderm formation (Kikuchi et al.,
2004).
DAPT treatment during different time intervals indicated that
Notch signaling pathway represses enteroendocrine cell
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interval precedes the onset of intestinal ascl1a expression. As DAPT
treatments must be performed during the same time interval to
trigger ascl1a upregulation, this strongly suggests that Ascl1a is the
mediator of Notch signaling in the zebraﬁsh intestine. This was
conﬁrmed by the fact that Ascl1a is absolutely required for the
induction of secretory cell fate upon Notch inactivation. All together,
these data indicate that, during zebraﬁsh embryogenesis, Notch
signaling represses the secretory cell fate by inhibiting ascl1a expres-
sion. The question if this is also the case during the continuous cell
renewal of the intestinal cells at late developmental stages and during
adulthood still remains to be addressed.
Diversity in the ARP/ASCL factors involved in the speciﬁcation of the
endocrine cells of the gastrointestinal tract
In the mouse intestine, the cell fate determinant of the
secretory lineage is Atoh1 (Shroyer et al., 2007; Yang et al.,
2001). In zebraﬁsh, the Atoh1 orthologs, atoh1a and atoh1b are
respectively not expressed or at very low level in the gastro-
intestinal tract (data not shown) and, as shown in this study, the
role of secretory cell fate determinant is held by Ascl1a. This is
quite surprising at ﬁrst glimpse since these two factors belong to
distinct families, namely the ATO and the ASCL group. However,
such cross-species diversity in the choice of ARP/ASCL factors
exists also in other tissues. For example, the group of ATO factors
efﬁciently induces neurogenesis in Drosophila, but very weakly in
Xenopus; inversely, NGN group proteins are potent neural indu-
cers in Xenopus but extremely weak inducers in ﬂies (Quan et al.,
2004). This diversity is also observed across organs in the same
species. For example, Ngn3 is the cell fate determinant of the
endocrine lineage in the murine pancreas and intestine (Jenny
et al., 2002; Mellitzer et al., 2010) but not in the stomach where
ASCL1 plays that role (Kokubu et al., 2008). This highlights the
diversity in the choice of the ARP/ASCL determinants within a
highly conserved mechanism of cell fate selection controlled by
Notch signaling and this diversity depends not only on the organ
considered but also on the species.
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